Recombinant, oral vaccine against Infectious Pancreatic Necrosis virus (IPNv) in Atlantic salmon (Salmo salar)

Key Features

  • First registered oral vaccine for IPNv, and now an intergral component of health management strategy for many salmon hatcheries

  • Contains unique Anitgen Protection Vehicle (APV) to protect the antigens through the stomach and deliver them intact to the hind gut where an immune response is initiated

  • Highly palatable

  • Can be used in very small fry

  • Excellent safety profile

  • Can be mixed on site or top-coated in a feed mill for larger volumes of feed

Key Beneftis

  • Allows for protection of fry in the hatchery at a very early stage in the production cycle

  • Reduces mortality due to IPNv of salmon fry in the hatchery

  • Allows for vaccination of fish in situ to eliminate handling and related stress

  • Allows farmers to optimise quality of smolt produced in the hatchery

  • Facilitates improved planning and management of batches of smolt being produced

< More vaccines

This website contains information on veterinary pharmaceutical and biological products based on international registration dossiers. The site may refer to products that are either not available in your country or are marketed under a different tradename. In addition, the safety and efficacy data and the withholding periods for a specific product may be different depending on local regulations. Please consult your veterinarian for further information.